Kairos Pharma, Ltd. (KAPA)
NYSEAMERICAN: KAPA · Real-Time Price · USD
1.810
0.00 (0.00%)
At close: Sep 17, 2026, 4:00 PM EDT
1.805
-0.005 (-0.27%)
After-hours: Sep 17, 2026, 4:57 PM EDT
Kairos Pharma Market Cap
Kairos Pharma has a market cap or net worth of $6.13 million as of September 17, 2026. Its market cap has decreased by -81.65% in one year.
Market Cap
6.13M
Enterprise Value
3.50M
1-Year Change
-81.65%
Ranking
Category
Stock Price
$1.81
ChartMarket Cap Chart
Since the IPO on September 16, 2024, Kairos Pharma's market cap has decreased from $33.39M to $6.13M, a decrease of -81.65%. That is a compound annual growth rate of -57.11%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2026 | 6.13M | -58.55% |
| Dec 31, 2025 | 14.78M | -24.29% |
| Dec 31, 2024 | 19.53M | -41.52% |
| Sep 16, 2024 | 33.39M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Enveric Biosciences | 6.94M |
| Skye Bioscience | 6.91M |
| Bolt Biotherapeutics | 6.51M |
| AIM ImmunoTech | 6.43M |
| Ernexa Therapeutics | 6.25M |
| Cardio Diagnostics Holdings | 6.08M |
| Lexaria Bioscience | 6.05M |
| NuCana | 5.81M |